ATYR
aTyr Pharma, Inc.
NASDAQ: ATYR · HEALTHCARE · BIOTECHNOLOGY
$0.81
+5.54% today
Updated 2026-04-30
Market cap
$76.98M
P/E ratio
—
P/S ratio
405.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $7
Volume
1.1M
aTyr Pharma, Inc. (ATYR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $422000.00 | $10.46M | $0.00 | $10.39M | $353000.00 | $235000.00 | $190000.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | +2377.5% | -100.0% | — | -96.6% | -33.4% | -19.1% |
| Cost of revenue | $540000.00 | — | — | — | $900000.00 | $713000.00 | $746000.00 | $14.05M | $17.29M | $1.30M | $1.70M | $2.74M | $1.54M | $1.55M |
| Gross profit | $-540000.00 | — | — | — | $-900000.00 | $-713000.00 | $-746000.00 | $-13.63M | $-6.84M | $-1.30M | $8.69M | $353000.00 | $235000.00 | $-1.36M |
| Gross margin | — | — | — | — | — | — | — | -3228.9% | -65.4% | — | 83.7% | 100.0% | 100.0% | -717.4% |
| R&D | $7.75M | $13.83M | $16.78M | $34.50M | $44.25M | $30.07M | $20.39M | $14.05M | $17.29M | $23.26M | $42.81M | $42.29M | $54.37M | $60.22M |
| SG&A | — | $5.71M | $6.78M | $13.11M | — | — | — | $9.35M | $9.07M | $10.75M | $13.98M | $12.98M | $13.78M | $17.60M |
| Operating income | $-12.60M | $-19.54M | $-23.55M | $-47.62M | $-59.34M | $-47.15M | $-32.82M | $-22.98M | $-15.91M | $-34.02M | $-46.40M | $-54.92M | $-67.91M | $-77.63M |
| Operating margin | — | — | — | — | — | — | — | -5445.0% | -152.2% | — | -446.8% | -15557.8% | -28899.6% | -40856.3% |
| EBITDA | $-12.05M | $-18.83M | $-22.73M | $-45.35M | $-57.00M | $-46.43M | $-32.07M | $-22.34M | $-14.64M | $-32.47M | $-44.71M | $-52.18M | $-66.37M | $-76.07M |
| EBITDA margin | — | — | — | — | — | — | — | -5294.5% | -140.1% | — | -430.5% | -14781.3% | -28244.3% | -40038.9% |
| EBIT | $-12.59M | $-19.54M | $-23.55M | $-46.22M | $-57.90M | $-47.15M | $-32.82M | $-22.98M | $-15.91M | $-33.78M | $-46.40M | $-54.92M | $-67.91M | $-77.63M |
| Interest expense | $272000.00 | $444000.00 | $832000.00 | — | — | — | — | — | — | — | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.61M | $-20.01M | $-24.35M | $-47.97M | $-57.85M | $-48.21M | $-34.52M | $-23.60M | $-16.22M | $-33.77M | $-45.34M | $-50.39M | $-64.02M | $-74.12M |
| Net income growth (YoY) | — | -13.7% | -21.7% | -97.0% | -20.6% | +16.7% | +28.4% | +31.6% | +31.3% | -108.1% | -34.3% | -11.1% | -27.1% | -15.8% |
| Profit margin | — | — | — | — | — | — | — | -5593.1% | -155.2% | — | -436.5% | -14274.5% | -27243.8% | -39009.5% |